Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.08%18.07B | 0.15%17.36B | 1.09%4.35B | 2.48%4.34B | -0.55%4.33B | -2.30%4.34B | 3.90%17.33B | -3.93%4.31B | -1.54%4.23B | 5.68%4.36B |
| Cost of revenue | 4.37%14.42B | -0.30%13.82B | -0.18%3.42B | 1.98%3.45B | -0.65%3.5B | -2.24%3.45B | 3.63%13.86B | -6.75%3.42B | 0.15%3.38B | 6.11%3.53B |
| Gross profit | 3.00%3.64B | 1.90%3.54B | 6.02%934M | 4.47%888M | -0.24%828M | -2.53%887M | 4.99%3.47B | 8.90%881M | -7.61%850M | 3.88%830M |
| Operating expense | 1.05%1.84B | 10.99%1.82B | 1.98%412M | 7.95%394M | 13.57%410M | 18.50%602M | 3.02%1.64B | -0.74%404M | 2.82%365M | 5.25%361M |
| Operating profit | 5.06%1.81B | -6.22%1.72B | 9.43%522M | 1.86%494M | -10.87%418M | -29.10%285M | 6.82%1.83B | 18.66%477M | -14.16%485M | 2.85%469M |
| Net non-operating interest income (expenses) | ||||||||||
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | 25.00%15M | 9.09%12M | 250.00%7M | -40.00%3M | 0 | 0.00%2M | 266.67%11M | -50.00%2M | 350.00%5M | 2M |
| Income before tax | 5.26%1.82B | -6.18%1.73B | 10.23%528M | 1.22%497M | -11.06%418M | -28.96%287M | 7.27%1.84B | 18.86%479M | -13.10%491M | 2.62%470M |
| Income tax | -3.29%529M | -0.55%547M | 41.88%166M | 0.64%157M | -10.74%133M | -28.91%91M | 8.70%550M | 48.10%117M | -14.75%156M | 0.00%149M |
| Net income | 9.21%1.29B | -8.50%1.18B | 0.28%363M | 1.19%339M | -10.90%286M | -28.99%196M | 6.68%1.29B | 11.73%362M | -12.30%335M | 3.88%321M |
| Net income continuous operations | 9.21%1.29B | -8.58%1.18B | 0.00%362M | 1.49%340M | -11.21%285M | -28.99%196M | 6.68%1.29B | 11.73%362M | -12.30%335M | 3.88%321M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 9.21%1.29B | -8.50%1.18B | 0.28%363M | 1.19%339M | -10.90%286M | -28.99%196M | 6.68%1.29B | 11.73%362M | -12.30%335M | 3.88%321M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 9.21%1.29B | -8.50%1.18B | 0.28%363M | 1.19%339M | -10.90%286M | -28.99%196M | 6.68%1.29B | 11.73%362M | -12.30%335M | 3.88%321M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 9.52%111.59 | -8.43%101.89 | 1.00%31.37 | 1.11%29.15 | -11.19%24.53 | -29.12%16.84 | 6.35%111.27 | 11.13%31.06 | -12.29%28.83 | 3.52%27.62 |
| Diluted earnings per share | 9.52%111.59 | -8.43%101.89 | 1.00%31.37 | 1.11%29.15 | -11.19%24.53 | -29.12%16.84 | 6.35%111.27 | 11.30%31.06 | -12.29%28.83 | 3.52%27.62 |
| Dividend per share | 3.45%45 | 1.16%43.5 | 0.00%22 | 0 | 2.38%21.5 | 0 | 22.86%43 | -2.22%22 | 0 | 68.00%21 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |